Keywords
edema, leukocytoclastic vasculitis, Seidlmayer purpura, erythematous rash, children
edema, leukocytoclastic vasculitis, Seidlmayer purpura, erythematous rash, children
Acute hemorrhagic edema of infancy (AHEI), also known as Seidlmayer purpura, is a rare cutaneous leukocytoclastic vasculitis. It was described for the first time in 1913 and currently there are more than 300 cases in the literature1. Initially it has been interpreted as a Henoch-Schönlein purpura variant, but now it is considered a distinct disease. Although it has a dramatic clinical presentation, it is a benign and self-limited disease2. We report the case of an 11-month-old girl who was referred to our unit for an erythematous rash appeared on the face and extremities, which was indicative of a rare but non negligible diagnosis.
An 11-month-old girl from France presented with fever and oval purpuric lesions on the face and extremities, which had appeared one hour before. In the previous week, she had bilateral conjunctivitis and gastroenteritis, treated with oral rehydration. At admission she was in good clinical condition and her vital signs were normal. Physical examination showed purpuric confluent elements with a cockade pattern on cheeks, left auricle, upper and lower limbs, particularly on distal ends, sparing trunk and back (Figure 1). Hands appeared edematous without joint swelling or tenderness. Bilateral conjunctivitis was still present. No other physical abnormalities were observed. Complete blood count, extended biochemistry, coagulation tests (prothrombin time, partial thromboplastin time, fibrinogen and D-dimer) and urinalysis were normal with C-reactive protein of 18.9 mg/l (normal value <5 mg/l) and procalcitonin of 0.88 ng/ml (normal value <0.05 ng/ml). During the hospitalization the child maintained good clinical condition, with stable vital parameters. Dermatological lesions showed a worsening clinical outcome, with increased diameter and colour intensity during the following three days from admission. Based on clinical and laboratory findings, a diagnosis of AHEI was made. We decided to not perform any therapy and after about two weeks lesions had a self-limited resolution. The child was monitored clinically for about six months and she did not present any relapse of the disease during the follow-up period.
The first description of AHEI was made by Snow in 19131. There have been approximately 300 cases reported in the literature2 under a variety of denominations: Seidlmayer purpura, Finkelstein disease, rosette form purpura, medallion-like purpura, infantile post-infectious iris-like purpura and edema3. AHEI is a rare cutaneous leukocytoclastic vasculitis that usually affects children aged between 4 and 24 months and it is more common in males2,4. Most cases of AHEI occur during winter, and almost of 75% of cases are preceded by infectious episodes, such as viral and bacterial infections of the upper respiratory tract, otitis media, conjunctivitis, bronchopneumonia, urinary tract infections and enteritis. Many organisms including adenovirus, varicella zoster virus, cytomegalovirus, rotavirus, herpes simplex virus, tuberculosis, streptococci, and staphylococci are associated with AHEI. Vaccinations or medications could also trigger AHEI5. In this case, the patient had a week-long history of bilateral conjunctivitis and gastroenteritis, compatible with a recent viral infection. A peculiar feature of AHEI is the unusual dramatic cutaneous eruption that contrasts with good general clinical condition (normal vital parameters with normal blood tests) that allowed to exclude more serious diseases. Diagnosis is clinical and it is classically detectable by observance of the clinical triad of symptoms: fever, edema and purpura6. Skin lesions are erythematous, annular, medallion-like, rosette-shaped purpuric plaques that cluster and often coalesce3. These lesions have a rapid onset and appear on face and extremities, sparing trunk and mucosal membranes3,4. The edema typically occurs on feet, hands, face and auricles, and can involve the scrotum in males2,7. In the majority of cases there is no visceral involvement and the disease is benign and self-limited. However, in the literature there are descriptions of cases of renal involvement, arthralgias and two cases of intestinal involvement followed by intussusception2.
Krause et al. suggested the following criteria for diagnosing AHEI8:
- Age <2 years;
- Purpuric or ecchymotic target-like skin lesions with edema on the head and face, with or without mucosal involvement;
- Lack of systemic disease or visceral involvement;
- Spontaneous recovery within few days or weeks.
Our patient presented all of the above conditions. Laboratory data are usually normal, but leukocytosis, thrombocytosis, eosinophilia and high levels of C-reactive protein and erythrocyte sedimentation rate can be observed7. Skin biopsy shows a leukocytoclastic vasculitis of the small dermal vessels characterized by infiltration of perivascular neutrophils, showing fragmentation of nuclei, resulting in fibrinoid necrosis9. Differential diagnoses include urticaria, erythema multiforme, idiopathic thrombocytopenia, meningococcemia, Kawasaki disease, Sweet syndrome, Gianotti-Crosti disease, drug-induced vasculitis, child abuse and trauma-induced purpura, but Henoch-Schönlein purpura is probably the most important9,10. Initially interpreted as a variant of Henoch-Schnölein purpura, now it is considered a distinct disease with different epidemiological, clinical and pathological features4.
Treatment of AHEI remains controversial; conservative management is the most frequently approach, because this disease is a self-limited condition4,7,9. AHEI certainly represents a challenge for the pediatrician at the emergency department and it requires, at least initially, a high level of suspicion for potentially serious pathologies that need adequate, urgent treatment such as for infectious (meningococcemia) or hematological diseases (autoimmune thrombocytopenia, coagulopathies). In fact, in our case some easily laboratory tests, such as complete blood count, prothrombin time, partial thromboplastin time, fibrinogen, D-dimer, C-reactive protein and procalcitonin tests were supportive in the rapid exclusion of these conditions. This approach, together with the typical benign course of the AHEI, quickly guaranteed the exclusion of these conditions, avoiding the execution of unnecessary and/or invasive diagnostic procedures and unrequired therapies.
We reported this case because it is expression of a rare and often under-recognized disease by pediatricians. A typical feature of AHEI is the discrepancy between dramatic cutaneous involvement and good clinical conditions of the affected children. This characteristic can reassure clinicians about the absence of a serious medical condition, but it is possible only through the knowledge of the disease.
We describe a case of AHEI with striking cutaneous involvement that resolved spontaneously. AHEI is an uncommon disease, often under-recognized. For this reason, it is crucial that physicians have the skill to recognize this self-limited disease to avoid parental anxiety and inappropriate procedures or therapies.
All data underlying the results are available as part of the article and no additional source data are required.
We received written informed consent from the patient’s family for the publication of this manuscript.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Yes
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Pediatric Emergency specialist
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Yes
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
References
1. Lava S, Milani G, Fossali E, Simonetti G, et al.: Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood. Clinical Reviews in Allergy & Immunology. 2017; 53 (3): 439-451 Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Pediatric kidney disease specialist with broad expertise with “childhood vasculitis”
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 17 Oct 19 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)